These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 36838752)

  • 1. A Comprehensive Overview of the Antibiotics Approved in the Last Two Decades: Retrospects and Prospects.
    Shi Z; Zhang J; Tian L; Xin L; Liang C; Ren X; Li M
    Molecules; 2023 Feb; 28(4):. PubMed ID: 36838752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent Drug-Repurposing-Driven Advances in the Discovery of Novel Antibiotics.
    Konreddy AK; Rani GU; Lee K; Choi Y
    Curr Med Chem; 2019; 26(28):5363-5388. PubMed ID: 29984648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The history of the development and changes of quinolone antibacterial agents].
    Takahashi H; Hayakawa I; Akimoto T
    Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are pleuromutilin antibiotics finally fit for human use?
    Novak R
    Ann N Y Acad Sci; 2011 Dec; 1241():71-81. PubMed ID: 22191527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applications of structure-based design to antibacterial drug discovery.
    Cain R; Narramore S; McPhillie M; Simmons K; Fishwick CW
    Bioorg Chem; 2014 Aug; 55():69-76. PubMed ID: 24962384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pleuromutilin and its derivatives-the lead compounds for novel antibiotics.
    Tang YZ; Liu YH; Chen JX
    Mini Rev Med Chem; 2012 Jan; 12(1):53-61. PubMed ID: 22070694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial Resistance: Antibiotics of Last Generation used in Clinical Practice and the Arise of Natural Products as New Therapeutic Alternatives.
    Corrêa RCG; Heleno SA; Alves MJ; Ferreira ICFR
    Curr Pharm Des; 2020; 26(8):815-837. PubMed ID: 32091328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 4(3H)-Quinazolinone derivatives: Promising antibacterial drug leads.
    Gatadi S; Lakshmi TV; Nanduri S
    Eur J Med Chem; 2019 May; 170():157-172. PubMed ID: 30884322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Designer aminoglycosides: the race to develop improved antibiotics and compounds for the treatment of human genetic diseases.
    Hainrichson M; Nudelman I; Baasov T
    Org Biomol Chem; 2008 Jan; 6(2):227-39. PubMed ID: 18174989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insights into aminoglycoside antibiotics and derivatives.
    Silva JG; Carvalho I
    Curr Med Chem; 2007; 14(10):1101-19. PubMed ID: 17456024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pleuromutilin antibiotics: a new class for human use.
    Novak R; Shlaes DM
    Curr Opin Investig Drugs; 2010 Feb; 11(2):182-91. PubMed ID: 20112168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient antibacterial agents: a review of the synthesis, biological evaluation and mechanism of pleuromutilin derivatives.
    Shang R; Wang J; Guo W; Liang J
    Curr Top Med Chem; 2013; 13(24):3013-25. PubMed ID: 24200363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of aminoglycoside antibiotics effective against resistant bacterial strains.
    Yang L; Ye XS
    Curr Top Med Chem; 2010; 10(18):1898-26. PubMed ID: 20615188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacology of polymyxins: new insights into an 'old' class of antibiotics.
    Velkov T; Roberts KD; Nation RL; Thompson PE; Li J
    Future Microbiol; 2013 Jun; 8(6):711-24. PubMed ID: 23701329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coping with antibiotic resistance: combining nanoparticles with antibiotics and other antimicrobial agents.
    Allahverdiyev AM; Kon KV; Abamor ES; Bagirova M; Rafailovich M
    Expert Rev Anti Infect Ther; 2011 Nov; 9(11):1035-52. PubMed ID: 22029522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aminoglycoside antibiotics in infectious diseases. An overview.
    Siegenthaler WE; Bonetti A; Luthy R
    Am J Med; 1986 Jun; 80(6B):2-14. PubMed ID: 3524216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterial targets to antimicrobial leads and development candidates.
    Rogers BL
    Curr Opin Drug Discov Devel; 2004 Mar; 7(2):211-22. PubMed ID: 15603255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive review on the anti-bacterial activity of 1,2,3-triazole hybrids.
    Zhang B
    Eur J Med Chem; 2019 Apr; 168():357-372. PubMed ID: 30826511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of Novel Polymyxin-Like Antibiotics.
    Velkov T; Roberts KD
    Adv Exp Med Biol; 2019; 1145():343-362. PubMed ID: 31364086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic-cell-penetrating peptide conjugates targeting challenging drug-resistant and intracellular pathogenic bacteria.
    Zeiders SM; Chmielewski J
    Chem Biol Drug Des; 2021 Nov; 98(5):762-778. PubMed ID: 34315189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.